Beijing Biostar Pharmaceuticals Co., Ltd. (HKG:2563)
Hong Kong · Delayed Price · Currency is HKD 3.860
-0.190 (-4.69%)
May 28, 2026, 3:53 PM HKT
HKG:2563 Market Cap
HKG:2563 has a market cap or net worth of 1.41 billion as of May 28, 2026. Its market cap has decreased by -75.16% in one year.
Market Cap
1.41B
Enterprise Value
901.21M
Revenue
37.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.86
Market Cap Chart
Since October 31, 2024, HKG:2563's market cap has decreased from 7.58B to 1.41B, a decrease of -81.44%. That is a compound annual growth rate of -65.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 1.41B | -21.06% |
| Dec 31, 2025 | 1.78B | -75.18% |
| Dec 31, 2024 | 7.18B | -5.29% |
| Oct 31, 2024 | 7.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HighTide Therapeutics | 1.90B |
| SinoMab BioScience | 1.80B |
| Mabpharm | 1.65B |
| Frontage Holdings | 1.56B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.47B |
| Cutia Therapeutics | 1.34B |
| Zhaoke Ophthalmology | 1.32B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.32B |